Učitavanje...
Might haplo “be the (better) match”?
In this issue of Blood, in a registry study by Kanate et al of reduced-intensity conditioning allogeneic blood or marrow transplantation (BMT) outcomes for lymphoma, HLA-haploidentical (haplo) transplantation with posttransplantation cyclophosphamide (PTCy) is associated with similar rates of relaps...
Spremljeno u:
| Izdano u: | Blood |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4760085/ https://ncbi.nlm.nih.gov/pubmed/26893397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-01-689042 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|